This review takes into consideration the principal vaccines developed against the SARS-
CoV-2 in this unprecedented period of Covid-19 pandemic. We evaluated the mechanism of …

The novel coronavirus (SARS‐CoV‐2) has turned into a life‐threatening pandemic disease
(Covid‐19). About 5% of patients with Covid‐19 have severe symptoms including septic …

To date, seven human coronaviruses (HCoVs) have been detected: HCoV‐NL63, HCoV‐
229E, HCoV‐HKU1, HCoV‐OC43, severe acute respiratory syndrome coronavirus (SARS …

Azithromycin (AZM) is a synthetic macrolide antibiotic effective against a broad range of
bacterial and mycobacterial infections. Due to an additional range of anti‐viral and anti …

The emergence of the SARS‐CoV‐2 Omicron variant (B. 1.1. 529) has created great global
distress. This variant of concern shows multiple sublineages, importantly B. 1.1. 529.1 (BA …

Ivermectin is an FDA‐approved drug for a parasitic disease that has broad antiviral activity.
This study aims to analyse the efficacy of ivermectin in improving the Covid‐19 outcomes …

Background: Coagulopathy and thromboembolic events are common in Covid‐19 patients
and are poor prognostic factors. Controversy exists regarding the potential of …

Summary Coronavirus disease 2019 (Covid‐19) is caused by severe acute respiratory
syndrome‐coronavirus‐2 (SARS‐CoV‐2) which is responsible for a global pandemic that …

Vitamin D has many protective properties and potential role against acute lung injury. Low
serum vitamin D is associated with high risk of pneumonia and development of acute …

The development of effective and safe COVID‐19 vaccines is a major move forward in our
global effort to control the SARS‐CoV‐2 pandemic. The aims of this study were (1) to …